It has been well understood for years that biochemical recurrence (BCR) after radical prostatectomy does not always translate into systemic progression or necessarily lead to prostate cancer metastasis and death. The “natural history” of BCR is actually very variable. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: biochemical recurrence, natural history, outcome, prostatectomy, surgery | 1 Comment »
A study reported this week in the Archives of Internal Medicine addresses the impact of biochemical recurrence on risk for prostate cancer-specific mortality (PCSM) among a cohort of more than 1,000 US veterans initially diagnosed and treated between 1991 and 1995. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: biochemical recurrence, long-term, outcome, radical prostatectomy, radiotherapy, veteran | 7 Comments »
Biochemical failure (also known as biochemical recurrence) after first-line treatment for prostate cancer is assessed based on a rising PSA level. This is a relatively common event and can happen shortly after first line treatment or many years later. The problem is that we really don’t know how important biochemical recurrence is in an individual patient at a specific point in time. After all, if a biochemical recurrence is never going to lead to clinical symptoms of prostate cancer (let alone prostate cancer-specific mortality), why would one want to treat it? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical recurrence, comorbidity, Management, risk, survival | Leave a comment »
A recent report in Cancer again seems to suggest that men with prostate cancer treated by radical prostatectomy (RP) who have a long time to biochemical recurrence (BCR) or a long PSA doubling time after BCR may have no higher overall risk of death than men who have no BCR at all. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical recurrence, mortality, PSA doubling time, radical prostatectomy | 1 Comment »
In today’s new reports we summarize information from recent papers dealing with:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: apex, biochemical recurrence, biopsy, Diagnosis, dissection, imaging, intrafascial, open, RALP, risk, robot-assisted, surgery, work-up | 1 Comment »
Researchers associated with the Duke Prostate Cancer have re-calibrated an older nomogram (used to predict the likelihood of biochemical recurrence after a radical prostatectomy or RP). The revised nomogram is now capable of predicting not only biochemical recurrence but also the much more clinically significant risk for an aggressive recurrence — in which the post-surgical PSA doubling time (PSADT) is < 9 months. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: aggressive, biochemical recurrence, PSA doubling time, PSADT, radical prostatectomy, surgery | Leave a comment »
Today’s prostate cancer news report deals with:
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical recurrence, hormone therapy, penile rehabilitation, radiation therapy, surgery | Leave a comment »
We have reported separately on a study of the long-term durability of erectile function following brachytherapy using permanent seed implantation. Other reports today address:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: allele, antiperspirant, biochemical recurrence, cause, communication, Diagnosis, Literacy, Prevention, PSA velocity, risk, salvage radical prostatectomy, tool | Leave a comment »
Comment on an article on PSA velocity and prediction of biopsy outcomes has been provided separately. Today’s other news includes reports on:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: active surveillance, age, biochemical recurrence, brachytherapy, hormone therapy, outcomes, pathology, vacuum erectile devices, VED | Leave a comment »
It has long been known that men with apparently localized prostate cancer can relapse many years after radical prostatectomy and/or other forms of treatment that appear to have been curative. A new study from researchers at the University of Washington appears to throw some more light on why this may occur. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical recurrence, disseminated tumor cells, DTC | 11 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 